Chilean pharmaceutical company
Chilean pharmaceutical company
Chileans spend nearly US$100 million a year on weight-loss treatment, according to La Tercera, as seven generic semaglutide applications — including Laboratorio Chile’s Selfix — await regulatory review, putting Novo …
You must be logged in to post a comment.